Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s) - Sandham, D; Chen, W; Hardman, C; Luo, J; Xue, L; Ogg, G; Erpenbeck, V (Wiley, 2019)